GRLA designed a single-story, 40,000 SF Current Good Manufacturing Practice (cGMP) pharmaceutical manufacturing building in Northbridge, Massachusetts for EyePoint Pharmaceuticals (EyePoint). This new facility allows EyePoint to expand its manufacturing capacity as they continue developing innovative therapeutics for patients with serious retinal disease.
The single-story building includes cleanroom manufacturing, cutting-edge laboratory space, a high-bay warehouse area with support offices as well as conference rooms, open office area and private offices.
GRLA closely collaborated with RP Masiello, and EyePoint to meticulously design a state-of-the-art building that achieves ISO-7 cleanroom classification and support spaces with ISO-8 classification designed to comply with the Food and Drug Administration (FDA) and European Medicines Agency (EMA) standards for production of therapeutics. A key feature is the walkable ceiling system installed above the pre-manufactured cleanroom system allowing ease of access to the overhead equipment with minimal disruption and downtime to the cleanroom space.
“GRLA did a great job serving as the architectural firm for EyePoint’s new Manufacturing Facility in Northbridge. They were focused on making sure the facility was both aesthetically pleasing and functionally efficient,” commended Joe Musiak, Sr. Director of Facilities & Engineering at EyePoint Pharmaceuticals.